Improved quality control of [(177)Lu]Lu-PSMA I&T

BACKGROUND: Targeted radionuclide therapy with [(177)Lu]Lu-PSMA I&T (zadavotide guraxetan) has proven high efficacy and safety in treating patients with advanced prostate cancer worldwide. Several methods to determine the radiochemical purity have been reported but also limitations in the HPLC a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraihammer, Martin, Garnuszek, Piotr, Bauman, Andreas, Maurin, Michael, Alejandre Lafont, Manuel, Haubner, Roland, von Guggenberg, Elisabeth, Gabriel, Michael, Decristoforo, Clemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043144/
https://www.ncbi.nlm.nih.gov/pubmed/36971890
http://dx.doi.org/10.1186/s41181-023-00191-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043144/
https://www.ncbi.nlm.nih.gov/pubmed/36971890
http://dx.doi.org/10.1186/s41181-023-00191-6

Ejemplares similares